Print ISSN: 2581-9356
Online ISSN: 2581-9364
CODEN : IIJOCV
IP Indian Journal of Orthodontics and Dentofacial Research (IJODR) open access, peer-reviewed quarterly journal publishing since 2015 and is published under the Khyati Education and Research Foundation (KERF), is registered as a non-profit society (under the society registration act, 1860), Government of India with the vision of various accredited vocational courses in healthcare, education, paramedical, yoga, publication, teaching and research activity, with the aim of faster and better dissemination of knowledge, we will be publishing the more...Case Report
Author Details :
Volume : 5, Issue : 4, Year : 2019
Article Page : 155-156
https://doi.org/10.18231/j.ijodr.2019.034
Abstract
Patients on anticonvulsants, calcium channel blockers and immuno-suppressants therapy often experience gingival overgrowth. Oral functions like mastication, speech, tooth eruption and aesthetics is hampered by gingival overgrowth. It impacts routine oral hygiene procedures which leads to increased plaque retention and resultant inflammatory overgrowth. Similar clinical and microscopic features of overgrowth are seen with the use of different drugs. Gingival overgrowth is treated by thorough oral prophylaxis i.e. scaling and polishing, drug substitution is done only if new drug has fewer adverse effects and if overgrowth persists surgical removal of excess soft tissue is advised. This article is a case report of commonly used calcium channel blocker Amlodipine which induces gingival overgrowth in few cases. It is treated by a combination of a rigorous oral hygiene regime, and in cases where aesthetics, function or speech are compromised surgery is advised.
Keywords: Gingival overgrowth, Drug, Management, Hyperplasia.
How to cite : Shende A , Kulshrestha R , Karambe P , Sumra N , Chowdhari M , Amlodipine induced gingival overgrowth- A case report. IP Indian J Orthod Dentofacial Res 2019;5(4):155-156
This is an Open Access (OA) journal, and articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as appropriate credit is given and the new creations are licensed under the identical terms.